Similar articles

• Hybrid cholecystokinin-A antagonists based on molecular modeling of lorglumide and L-364,718.

  van der Bent A, Blommaert AG, Melman CT, IJzerman AP, van Wijngaarden I, Soudijn W. van der Bent A, et al. J Med Chem. 1992 Mar 20;35(6):1042-9. doi: 10.1021/jm00084a009. J Med Chem. 1992. PMID: 1552499
• Effects of three different cholecystokinin receptor antagonists on basal and stimulated insulin and glucagon secretion in mice.

  Karlsson S, Ahrén B. Karlsson S, et al. Acta Physiol Scand. 1989 Mar;135(3):271-8. doi: 10.1111/j.1748-1716.1989.tb08577.x. Acta Physiol Scand. 1989. PMID: 2648765
• Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.

  Dembinski A, Jaworek J, Konturek PK, Konturek SJ, Warzecha Z. Dembinski A, et al. J Physiol. 1989 Apr;411:419-35. doi: 10.1113/jphysiol.1989.sp017581. J Physiol. 1989. PMID: 2614728 Free PMC article.
• [Cholecystokinin and its antagonists: effects on digestive motility].

  Bruley des Varannes S, Cloarec D, Dubois A, Galmiche JP. Bruley des Varannes S, et al. Gastroenterol Clin Biol. 1991;15(10):744-57. Gastroenterol Clin Biol. 1991. PMID: 1816015 Review. French. No abstract available.
• Recent advances in the chemistry of cholecystokinin receptor ligands (agonists and antagonists).

  de Tullio P, Delarge J, Pirotte B. de Tullio P, et al. Curr Med Chem. 1999 Jun;6(6):433-55. Curr Med Chem. 1999. PMID: 10213792 Review.